<DOC>
	<DOCNO>NCT02834533</DOCNO>
	<brief_summary>Objective : To investigate role virtual reality ( VR ) pair robotic-assisted gait training ( RAGT ) compare RAGT alone patient Multiple Sclerosis ( MS ) . Method : A Randomized , double-blind , control clinical trial carry forty patient relapse remit MS. All patient randomize two group . One group practice Lokomat without VR ( group G1 ) , one Lokomat VR ( G2 ) . Both group perform 40-1h-training session Lokomat ( 3 time week ) . A skilled-blinded neurologist psychologist administer clinical neuropsychological scale . All clinical test perform begin ( T0 ) end ( T1 ) rehabilitative program .</brief_summary>
	<brief_title>Role Virtual Reality MS Rehabilitation</brief_title>
	<detailed_description>METHODS The present study single-blind randomized trial , conduct accord Declaration Helsinki , guideline Good Clinical Practice , ( CONSORT ) Statement guideline . The study protocol approve Institutional Review Board Ethics Committee ( project number : 24/2013 ) . One hundred fifty consecutive outpatient relapsing-remitting multiple sclerosis gait and/or balance disturbance , attend Laboratory Robotic Neurorehabilitation IRCCS Neurolesi Bonino-Pulejo ( Messina , Italy ) January 2015 January 2016 , invite participate study , screen study eligibility . Inclusion/exclusion criterion Inclusion criterion : age 30-65 year ; severe walk disability Expanded Disability Status Score 3.5 6.0 ( Piramidal subitem ≥3 ) ; Montreal Cognitive Assessment score ≥24 ; absence concomitant neurological orthopedic condition may interfere ambulation ; stable pharmacological therapy least 6 month . Exclusion criterion : multiple sclerosis relapse three month prior recruitment ; presence paroxysmal vertigo ; low limb botulinum toxin injection within previous 12 week ; cardiorespiratory instability ; high-risk spontaneous fracture ; lower-limb skin lesion phlebitis/thrombosis ; 130 kg body weight . Randomization Forty 150 outpatient relapse remit multiple sclerosis form , accord Polman criteria14 select January 2015-2016 , enrol randomize allocate either Group1 ( G1 i.e . Lokomat-Nanos ) Group2 ( G2 i.e . Lokomat-Pro ) , show fig 1 . The subject randomly assign one two treatment group , use simple randomization scheme generate software ( www.randomization.com ) . Individual , sequentially numbered index card random assignment prepare . The index card fold place sealed opaque envelope . A physician member research team , blind baseline examination finding , open envelope attribute intervention accord group assignment .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Severe walk disability Expanded Disability Status Score ( EDSS ) 3.5 6.0 ( Pyramidal subitem ≥3 ) Montreal Cognitive Assessment score ≥24 Absence concomitant neurological orthopedic condition may interfere ambulation . MS relapse three month prior recruitment Not well defined pharmacological therapy ; presence paroxysmal vertigo Lower limb botulinum toxin injection within previous 12 week Cardiorespiratory instability highrisk spontaneous fracture Lowerlimb skin lesion phlebitis/thrombosis More 130kg body weight</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Lokomat ;</keyword>
	<keyword>robotic rehabilitation .</keyword>
	<keyword>Multiple Sclerosis ;</keyword>
	<keyword>Virtual reality</keyword>
</DOC>